Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
Harrison, Lee H; Shutt, Kathleen A; Schmink, Susanna E; Marsh, Jane W; Harcourt, Brian H; Wang, Xin; Whitney, Anne M; Stephens, David S; Cohn, Amanda A; Messonnier, Nancy E; Mayer, Leonard W.
J Infect Dis
; 201(8): 1208-24, 2010 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-20199241
Significance of Meningococcal Hyperinvasive Clonal Complexes and their Influence on Vaccines Development.
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine.
Unveiling New Aspects of Meningococcal Carriage and Disease Prevention.
Invasive meningococcal disease in the 21st centuryan update for the clinician.
Strength in numbers: comparing vaccine signatures the modular way.
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
Meningococcal vaccines: Current state and future outlook.
[Molecular characteristics of serogroup B <i>neisseria meningitidis</i>, China].
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.